Normal view MARC view ISBD view

Anti phospholipid antibodies and malignancy

In Hematology/Oncology Clinics of North America
Contributor(s): Shen YM | yu-min.shen@utssouthwestern.edu | Pham C.
Material type: materialTypeLabelArticleSeries: Vol 22 Issues 1.Publisher: 2008Description: 121-130.Subject(s): Cancer | Anti phospholipid | DDC classification: In: Hematology/Oncology Clinics of North AmericaSummary: Antiphospholipid antibody syndrome is characterized clinically by venous or arterial thrombosis, recurrent fetal loss, or placental insufficiency in women. This article describes the prevalence of malignancy, the manifestations, and the prognosis for this condition.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)

Antiphospholipid antibody syndrome is characterized clinically by venous or arterial thrombosis, recurrent fetal loss, or placental insufficiency in women. This article describes the prevalence of malignancy, the manifestations, and the prognosis for this condition.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha